Cynosure Group’s GE HealthCare GEHC Stock Holding History

Cynosure Group’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.57M	Sell	20,645 -4,344,817	-100%	-$343M	0.2%	45
2025 Q4	$46.4M	Buy	4,365,462 +4,344,817	+21,045%	+$339M	4.72%	5
2025 Q3	$1.55M	Hold	20,645	–	–	0.17%	52
2025 Q2	$1.53M	Hold	20,645	–	–	0.17%	60
2025 Q1	$1.67M	Sell	20,645 -11,727	-36%	-$1.01M	0.23%	51
2024 Q4	$2.53M	Sell	32,372 -160	-0.5%	-$13.6K	0.38%	35
2024 Q3	$3.05M	Buy	32,532 +11,890	+58%	+$998K	0.45%	35
2024 Q2	$1.61M	Sell	20,642 -11	-0.1%	-$897	0.26%	53
2024 Q1	$1.88M	Sell	20,653 -113	-0.5%	-$9.4K	0.34%	41
2023 Q4	$1.61M	Buy	20,766 +17	+0.1%	+$1.19K	0.29%	73
2023 Q3	$1.41M	Sell	20,749 -3,958	-16%	-$288K	0.43%	54
2023 Q2	$2.01M	Buy	24,707 +15,819	+178%	+$1.26M	0.6%	42
2023 Q1	$729K	Buy	+8,888	New	+$635K	1.1%	23

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Cynosure Group's GEHC Position: Q1 2026 in Review

Cynosure Group reduced its GE HealthCare (GEHC) stake by 100% in Q1 2026, selling an estimated $343M and leaving 20,645 shares worth $1.57M. The position accounts for 0.2% of the portfolio, ranked #45.

Cynosure Group first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $46.4M in Q4 2025. 1,264 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Cynosure Group held 20,645 shares of GE HealthCare worth $1.57M as of Q1 2026.
Cynosure Group sold 4,344,817 GE HealthCare shares in Q1 2026, an estimated $343M.
GE HealthCare made up 0.2% of Cynosure Group's portfolio in Q1 2026, its #45 holding.
Cynosure Group first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
Cynosure Group's GE HealthCare position peaked at $46.4M in Q4 2025.
1,264 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.